SEC Form D · Amendment · filed April 8, 2024
Melt Pharmaceuticals, Inc
Offering
$47.8M
Sold
$42.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRENTWOOD, TN
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗